1887
Editorial Open Access
Like 0
Preview this article:

There is no abstract available.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2021.26.45.2101050
2021-11-11
2021-11-28
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2021.26.45.2101050
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/26/45/eurosurv-26-45-1.html?itemId=/content/10.2807/1560-7917.ES.2021.26.45.2101050&mimeType=html&fmt=ahah

References

  1. Huggett JF, Moran-Gilad J, Lee JE. COVID-19 new diagnostics development: novel detection methods for SARS-CoV-2 infection and considerations for their translation to routine use. Curr Opin Pulm Med. 2021;27(3):155-62.  https://doi.org/10.1097/MCP.0000000000000768  PMID: 33654014 
  2. Puyskens A, Krause E, Michel J, Nübling CM, Scheiblauer H, Bourquain D, et al. Establishment of a specimen panel for the decentralised technical evaluation of the sensitivity of 31 rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021. Euro Surveill. 2021;26(44):2100442.  https://doi.org/10.2807/1560-7917.ES.2021.26.44.2100442  PMID: 34738516 
  3. Scheiblauer H, Filomena A, Nitsche A, Puyskens A, Corman VM, Drosten C, et al. Comparative sensitivity evaluation for 122 CE-marked rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021. Euro Surveill. 2021;26(44):2100441.  https://doi.org/10.2807/1560-7917.ES.2021.26.44.2100441  PMID: 34738515 
  4. Walle I, Leitmeyer K, Broberg EK. the European COVID-19 microbiological laboratories group. Meta-analysis of the clinical performance of commercial SARS-CoV-2 nucleic acid and antibody tests up to 22 August 2020. Euro Surveill. 2021;26(45):2001675.
  5. Evans D, Cowen S, Kammel M, O’Sullivan DM, Stewart G, Grunert HP, et al. The dangers of using Cq to quantify nucleic acid in biological samples; a lesson from COVID-19. Clin Chem. 2021;hvab219.  https://doi.org/10.1093/clinchem/hvab219  PMID: 34633030 
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error